Skip to main content
Moogene Medi Co., Ltd. logo

Moogene Medi Co., Ltd. — Investor Relations & Filings

Ticker · 322970 ISIN · KR7322970005 KO Manufacturing
Open in API
Filings indexed 183 across all filing types
Latest filing 2024-02-19 Director's Dealing
Country KR South Korea
Listing KO 322970

About Moogene Medi Co., Ltd.

http://moogene.com/eng/

Moogene Medi Co., Ltd. is a biotechnology company specializing in nanomedicine and the development of advanced drug delivery systems. The company focuses on its proprietary Lipid Nanoparticle (LNP) carrier system and other nano-bio technologies to safely and effectively transport a range of therapeutic agents, including genes, chemicals, and proteins. Its primary mission is to create novel therapeutics for severe and incurable diseases. The development pipeline includes gene therapies for conditions such as cancer, metabolic diseases, and androgenic alopecia, utilizing technologies like CRISPR/Cas9 gene editing. Moogene Medi operates an aseptic, GMP-grade facility, providing end-to-end support from initial research to GMP-scale production for clinical studies.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed in Korea. It details the shareholding changes of a director (CEO Yoon Tae-jong) of the company 'Moogene Medi'. This type of filing is specifically categorized as a 'Director's Dealing' (DIRS) report, as it tracks insider transactions and changes in ownership status by company executives.
2024-02-19 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the acquisition of shares by a major shareholder (Yoon Tae-jong) and his special relations in the company 'Moogene Medi'. This type of filing is specifically used to notify the market when a person or entity crosses a significant ownership threshold (typically 5%). In the provided classification schema, this falls under 'Major Shareholding Notification'.
2024-02-19 Korean
증권발행결과(자율공시)(제3자배정 유상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a third-party capital increase/private placement). It details the number of shares issued, the amount raised, and the payment method (cash and debt-to-equity swap). This falls under the category of share issuance and capital changes.
2023-12-15 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 90% confidence The document is a short regulatory notice regarding the setting of a record date for the purpose of holding an Annual General Meeting (AGM). It does not contain the full AGM materials or proxy statements, but rather serves as a formal regulatory announcement of the record date for shareholder rights. Given the nature of the announcement regarding meeting preparation and the lack of a specific category for 'Record Date' notices, it falls under the general regulatory filing category.
2023-12-14 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) from a Korean company, MuJinMedi, specifically detailing a 'Decision on Paid-in Capital Increase' (유상증자결정). This document outlines the issuance of new shares, the purpose of the capital raise (operating funds and debt repayment), the third-party allocation details, and the specific terms of the convertible preferred shares. In the context of Korean corporate filings (DART system), this is a standard regulatory disclosure regarding capital changes and share issuance, which falls under the 'Share Issue/Capital Change' category.
2023-12-07 Korean
기업설명회(IR)개최결과
Report Publication Announcement Classification · 100% confidence The document is a short notification (under 1,000 characters) announcing the results of an Investor Relations (IR) event held on 2023-11-23. It provides details about the event's date, location, attendees, and agenda, and confirms that the IR materials have been posted to the Korea Exchange's disclosure system. Since it is a brief announcement regarding the occurrence of an event and the availability of materials rather than the presentation itself, it falls under the Report Publication Announcement (RPA) category.
2023-11-24 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.